IDENTIFICATION OF SOLUBLE APO-1 IN SUPERNATANTS OF HUMAN B-CELL AND T-CELL LINES AND INCREASED SERUM LEVELS IN B-CELL AND T-CELL LEUKEMIAS

被引:143
作者
KNIPPING, E
DEBATIN, KM
STRICKER, K
HEILIG, B
EDER, A
KRAMMER, PH
机构
[1] GERMAN CANC RES CTR, DIV IMMUNOGENET, TUMORIMMUNOL PROGRAM, D-69120 HEIDELBERG, GERMANY
[2] UNIV HEIDELBERG, CHILDRENS HOSP, HEMATOL ONCOL SECT, W-6900 HEIDELBERG, GERMANY
[3] UNIV HEIDELBERG, MED KLIN 5, HEIDELBERG, GERMANY
[4] NIH, BIOL MODIFIERS PROGRAM, BETHESDA, MD 20892 USA
[5] BENDER MEDSYST, VIENNA, AUSTRIA
关键词
D O I
10.1182/blood.V85.6.1562.bloodjournal8561562
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cell-surface protein APO-1 is a member of the nerve growth factor (NGF)/tumor necrosis factor (TNF) receptor superfamily. APO-1 mediates apoptosis in susceptible cells upon stimulation with the monoclonal antibody anti-APO-1 or upon binding of its natural ligand. Soluble receptors had previously been identified for most members of the NGF/TNF receptor superfamily. Recently, a soluble form of APO-1 (sAPO-1) was described. We established a sandwich enzyme-linked immunosorbent assay to detect sAPO-1 in culture supernatants of human cell lines and in human sera. sAPO-1 was found in culture supernatants of different human B- and T-cell lines. Molecular weights of sAPO-1 and membrane APO-1 were similar. In addition, in comparison to healthy donors, sera from patients with different high- and low-grade malignant B- and T-cell leukemias and lymphomas contained increased levels of sAPO-1. These findings may have implications for the growth of leukemias and the diagnostic monitoring of individual patients. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:1562 / 1569
页数:8
相关论文
共 65 条
  • [1] ADERKA D, 1991, CANCER RES, V51, P5602
  • [2] A SOLUBLE RECEPTOR FOR INTERLEUKIN-1-BETA ENCODED BY VACCINIA VIRUS - A NOVEL MECHANISM OF VIRUS MODULATION OF THE HOST RESPONSE TO INFECTION
    ALCAMI, A
    SMITH, GL
    [J]. CELL, 1992, 71 (01) : 153 - 167
  • [3] FAS TRANSDUCES ACTIVATION SIGNALS IN NORMAL HUMAN T-LYMPHOCYTES
    ALDERSON, MR
    ARMITAGE, RJ
    MARASKOVSKY, E
    TOUGH, TW
    ROUX, E
    SCHOOLEY, K
    RAMSDELL, F
    LYNCH, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2231 - 2235
  • [4] ALTOMONTE M, 1993, CANCER RES, V53, P3343
  • [5] Black P H, 1980, Adv Cancer Res, V32, P75, DOI 10.1016/S0065-230X(08)60361-9
  • [6] CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261
  • [7] CHAMULEAU MED, 1992, TRANSPLANTATION, V54, P932
  • [8] PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE
    CHENG, JH
    ZHOU, T
    LIU, CD
    SHAPIRO, JP
    BRAUER, MJ
    KIEFER, MC
    BARR, PJ
    MOUNTZ, JD
    [J]. SCIENCE, 1994, 263 (5154) : 1759 - 1762
  • [9] DABATIN KM, IN PRESS LEUKEMIA
  • [10] HIGH EXPRESSION OF APO-1 (CD95) ON T-LYMPHOCYTES FROM HUMAN IMMUNODEFICIENCY VIRUS-1-INFECTED CHILDREN
    DEBATIN, KM
    FAHRIGFAISSNER, A
    ENENKELSTOODT, S
    KREUZ, W
    BENNER, A
    KRAMMER, P
    [J]. BLOOD, 1994, 83 (10) : 3101 - 3103